Business Standard

Omicron sub-variant BF.7 behind China surge sparks concerns in India

Amid rising concerns around Omicron sub-variant that caused surge in China, the network of government scientists and labs responsible for genome-sequencing strains of Covid-19 virus are likely to meet

Covid test
Premium

Representative Image

BS Web Team New Delhi
Amid rising concerns around the Omicron sub-variant that has caused the recent infection surge in China, the network of government scientists and labs responsible for genome-sequencing strains of the Covid-19 virus are likely to meet this week to discuss the looming threat in India, Livemint reported. 

The fast-mutating and virulent Omicron variant BF.7 and its spread in India will be discussed by the Indian SARS-CoV-2 Consortium on Genomics (INSACOG).

INSACOG is a consortium of 54 laboratories to monitor the genomic variations in SARS-CoV-2.

Department of Biotechnology (DBT), National Technical Group of Immunization (NTAGI), Indian Council Medical Research (ICMR), National Institute

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in